Imaging fungal infections in children

被引:26
作者
Ankrah A.O. [1 ,2 ]
Sathekge M.M. [2 ]
Dierckx R.A.J.O. [1 ]
Glaudemans A.W.J.M. [1 ]
机构
[1] Department of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, University of Groningen, Hanzeplein 1, Groningen
[2] Department of Nuclear Medicine, University of Pretoria and Steve Biko Academic Hospital, Pretoria
关键词
Aspergillus; Candida; Children; FDG-PET; Fungal infections; Hybrid imaging;
D O I
10.1007/s40336-015-0159-2
中图分类号
学科分类号
摘要
Fungal infections in children rarely occur, but continue to have a high morbidity and mortality despite the development of newer antifungal agents. It is essential for these infections to be diagnosed at the earliest possible stage so appropriate treatment can be initiated promptly. The addition of high-resolution computer tomography (HR CT) has helped in early diagnosis making; however, it lacks both sensitivity and specificity. Metabolic changes precede anatomical changes and hybrid imaging with positron emission tomography (PET) integrated with imaging modalities with high anatomical resolution such as CT or magnetic resonance imaging (MRI) is likely to detect these infections at an earlier stage with higher diagnostic accuracy rates. Several authors presented papers highlighting the advantages of PET/CT in imaging fungal infections. These papers, however, usually involve a limited number of patients and mostly adults. Fungal infections behave different in children than in adults, since there are differences in epidemiology, imaging findings, and response to treatment with antifungal drugs. This paper reviews the literature and explores the use of hybrid imaging for diagnosis and therapy decision making in children with fungal infections. © 2016, The Author(s).
引用
收藏
页码:57 / 72
页数:15
相关论文
共 111 条
[1]  
Dornbusch H.J., Manzoni P., Roilides E., Walsh T.J., Groll A.H., Invasive fungal infections in children, Pediatr Infect Dis J, 28, 8, pp. 734-737, (2009)
[2]  
Ozsevik S.N., Sensoy G., Karli A., Albayrak C., Dagdemir A., Belet N., Et al., Invasive fungal infections in children with hematologic and malignant diseases, J Pediatr Hematol Oncol, 37, 2, pp. e69-e72, (2015)
[3]  
De Pascale G., Tumbarello M., Fungal infections in the ICU: advances in treatment and diagnosis, Curr Opin Crit Care, 21, 5, pp. 421-429, (2015)
[4]  
Brissaud O., Guichoux J., Harambat J., Tandonnet O., Zaoutis T., Invasive fungal disease in PICU: epidemiology and risk factors, Ann Intensive Care, 2, 1, (2012)
[5]  
Steinbach W.J., Epidemiology of invasive fungal infections in neonates and children, Clin Microbiol Infect, 16, 9, pp. 1321-1327, (2010)
[6]  
Posfay-Barbe K.M., Zerr D.M., Pittet D., Infection control in paediatrics, Lancet Infect Dis, 8, 1, pp. 19-31, (2008)
[7]  
Blyth C.C., Palasanthiran P., O'Brien T.A., Antifungal therapy in children with invasive fungal infections: a systematic review, Pediatrics, 119, 4, pp. 772-784, (2007)
[8]  
Kullberg B.J., Arendrup M.C., Invasive Candidiasis, N Engl J Med, 373, 15, pp. 1445-1456, (2015)
[9]  
Rammaert B., Desjardins A., Lortholary O., New insights into hepatosplenic candidosis, a manifestation of chronic disseminated candidiasis, Mycoses, 55, 3, pp. e74-e84, (2012)
[10]  
Kosmidis C., Denning D.W., Republished: the clinical spectrum of pulmonary aspergillosis, Postgrad Med J, 91, 1077, pp. 403-410, (2015)